5666 E STATE ST
Metabolic medicine provider specializing in medical weight management, bariatric care, and GLP-1 treatment in Rockford, Illinois.
Need a clinic that prescribes Ozempic, Wegovy, or Mounjaro? Our directory lists 5 verified providers serving Rockford, Illinois (147,486 residents · 34.2% adult obesity).
Each clinic below offers GLP-1 weight-loss medications including Ozempic, Wegovy, Mounjaro, and Zepbound. Compare ratings, services, and pricing — then book directly or via our partner directory at GLP1Maps.com.
5666 E STATE ST
Metabolic medicine provider specializing in medical weight management, bariatric care, and GLP-1 treatment in Rockford, Illinois.
5668 E State St, Rockford, IL 61108
Dr. Sameer Ansar, M.D. is a endocrinology specialist in Rockford, Illinois.
5666 E State St, Rockford, IL 61108
Dr. John Alexander, M.D. is a obesity medicine specialist in Rockford, Illinois.
2528 Sandhutton Ave, Rockford, IL 61108
Dr. Dileep Kumar Reddy Regalla is a obesity medicine specialist in Rockford, Illinois.
5666 E State St, Rockford, IL 61108
Dr. John Alexander, M.D. is a obesity medicine specialist in Rockford, Illinois.
Full directory of verified providers on GLP1Maps.com
Get an AI Receptionist that books patients 24/7 — from GLP1Receptionist.com
Read Shep's Method — patient guide to GLP-1 success at ShepsMethod.com
Independent network of GLP-1 resources serving Rockford and patients across the U.S.
Choosing the right GLP-1 provider in Rockford matters. Look for clinics that offer:
GLP-1 receptor agonists work by mimicking a hormone that regulates appetite and blood sugar. The main options:
Illinois Medicaid covers GLP-1 for diabetes and weight management (PA required).
For state regulation info, see the Illinois Medical Board.
Our directory lists 5 verified GLP-1 clinics in the Rockford area, with rankings based on patient reviews, services offered, and verified provider status.
Illinois Medicaid covers GLP-1 for diabetes and weight management (PA required).
Following the FDA's April 2026 503B ruling, compounded semaglutide and tirzepatide are no longer available from most U.S. pharmacies. Most clinics now prescribe FDA-approved Ozempic, Wegovy, Mounjaro, or Zepbound.